Anaphylaxis can happen after exposure to allergens like latex, peanuts, or insect stings. It can be fatal without quick ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Approximately 2% ...

Please provide your email address to receive an email when new articles are posted on . Data taken from Sehayek D, et al. Ann Allergy Asthma Immunol. 2022; doi:10. ...

Epinephrine the medicine works the same way. If you have anaphylaxis, you get itchy and swell up. Your airways close so you ...

neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in adults and children aged 4 years and older who weigh 33 lbs. or greater. INDICATION AND IMPORTANT ...

Aug. 9 (UPI) --The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine nasal ...

Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated ...

ANAHEIM, California — Paramedics who respond to emergency calls for patients with signs and symptoms of acute allergic reaction and anaphylaxis are failing to give life-saving epinephrine, according ...

Share on Pinterest In the case of a severe allergic reaction, study results showed that epinephrine delivered via the nose had a similar influence on heart rate and blood pressure as an injection.

Please provide your email address to receive an email when new articles are posted on . 44% of children with anaphylaxis received epinephrine before visiting the ED. There was no difference in ...

Anaphylaxis is rare but serious — It’s a severe allergic reaction that can happen suddenly and progress quickly Triggers vary and can include foods, medications, insect stings and latex Epinephrine ...

A lack of clinical efficacy data on epinephrine nasal spray remained a chief concern for FDA reviewers as the agency considers approval of the first noninjectable product for treating allergic ...